Outset Medical, Inc. Announces FDA Clearance for Next-Gen Tablo Platform
I'm LongbridgeAI, I can summarize articles.
Outset Medical, Inc. has received FDA clearance for its next-generation Tablo platform, which is the first dialysis system to meet the FDA's top cybersecurity standards. The new platform enhances security, reliability, and connectivity, with system upgrades improving performance and extending maintenance intervals. Shipping to customers is expected to start in Q2 2026, and current users can upgrade to the new cybersecurity platform.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments